PCV32 ECONOMIC EVALUATION OF ATORVASTATIN AND ROSUVASTATIN USING HEAD-TO-HEAD RANDOMIZED CONTROLLED TRIAL WITH UP-TITRATION OF DRUG DOSES TO OBTAIN THERAPEUTIC TARGETS FOR LDL-CHOLESTEROL
Nov 1, 2008, 00:00
10.1016/S1098-3015(10)66330-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)66330-9/fulltext
Title :
PCV32 ECONOMIC EVALUATION OF ATORVASTATIN AND ROSUVASTATIN USING HEAD-TO-HEAD RANDOMIZED CONTROLLED TRIAL WITH UP-TITRATION OF DRUG DOSES TO OBTAIN THERAPEUTIC TARGETS FOR LDL-CHOLESTEROL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66330-9&doi=10.1016/S1098-3015(10)66330-9
First page :
Section Title :
Open access? :
No
Section Order :
163